News Focus
News Focus
Replies to #74098 on Biotech Values
icon url

DewDiligence

03/09/09 10:10 AM

#74111 RE: DewDiligence #74098

MRK is off 8%, but this is probably not because investors think MRK is overpaying for SGP. Rather, the reason for the drop is probably that the merger has an Achilles heel with respect to SGP’s ex-US rights to the blockbuster, Remicade.